What they do
Healx utilizes its AI platform, HealNet, to analyze extensive biomedical data and identify novel drug combinations and repositioning opportunities for rare diseases. The system serves patient groups, academic institutions, and biopharma partners looking to accelerate therapies into clinical trials.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Rare disease therapies
- Product type
- Platform software
- Stage
- Series B
- Headquarters
- Cambridge, UK
- Region
- Europe
- Founded
- 2014
- Total funding
- $103M raised
Notable investors: Atomico, Intel Capital, Balderton Capital, Global Brain.